Tag:
Tioga Pharmaceuticals
Latest Headlines
Latest Headlines
UPDATED: Tioga nabs $10M VC deal amid PhIII for bowel disorder drug
Tioga Pharmaceuticals has grabbed $10 million in equity for a Series B round as the company funds late-stage development of its key drug for a bowel disorder.
Tioga raises $18M for Phase III clinical trial
San Diego-based Tioga Pharmaceuticals has rounded up $18 million to fund a late-stage trial which will enroll 600 patients with diarrhea predominant Irritable Bowel Syndrome. Forward Ventures, New
